{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:29:16Z","timestamp":1789712956171,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA030155"],"award-info":[{"award-number":["R01AA030155"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bcp.2024.116569","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T05:44:52Z","timestamp":1728539092000},"page":"116569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["Non-additivity of the functional properties of individual P450 species and its manifestation in the effects of alcohol consumption on the metabolism of ketamine and amitriptyline"],"prefix":"10.1016","volume":"230","author":[{"given":"Kannapiran","family":"Ponraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari A.","family":"Gaither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Kumar Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda","family":"Davydova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaman","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8520-0033","authenticated-orcid":false,"given":"Dmitri R.","family":"Davydov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116569_b0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2024.116569_b0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrg1428","article-title":"Pharmacogenetics - five decades of therapeutic lessons from genetic diversity","volume":"5","author":"Meyer","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bcp.2024.116569_b0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2015.10.006","article-title":"Precision medicine and rare genetic variants","volume":"37","author":"Lauschke","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1134\/S1990750816010042","article-title":"Molecular organization of the microsomal oxidative system: a new connotation for an old term","volume":"10","author":"Davydov","year":"2016","journal-title":"Biochem. Moscow-Suppl. Ser. B-Biomed. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2024.116569_b0025","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.tips.2021.09.004","article-title":"Assembling the P450 puzzle: on the sources of nonadditivity in drug metabolism","volume":"42","author":"Davydov","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2024.116569_b0030","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40262-014-0190-x","article-title":"Pharmacokinetic and pharmacodynamic drug Interactions with ethanol (alcohol)","volume":"53","author":"Chan","year":"2014","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0035","first-page":"40","article-title":"Alcohol and medication interactions","volume":"23","author":"Weathermon","year":"1999","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.bcp.2024.116569_b0040","unstructured":"W.-C. Tom, Alcohol-related drug interactions. Pharmacist\u2019s Letter\/Prescriber\u2019s Letter 24(1) (2008) 240106."},{"issue":"10","key":"10.1016\/j.bcp.2024.116569_b0045","first-page":"760","article-title":"Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens","volume":"46","author":"Djordjevic","year":"1998","journal-title":"Pathol. Biol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116569_b0050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0369-8114(01)00235-8","article-title":"Alcohol-xenobiotics interactions. Role of cytochrome P450 2E1","volume":"49","author":"Meskar","year":"2001","journal-title":"Pathol. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116569_b0055","first-page":"991","article-title":"Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968\u20131998) - A review","volume":"23","author":"Lieber","year":"1999","journal-title":"Alcohol.-Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.bcp.2024.116569_b0060","first-page":"303","article-title":"Effect of long-term alcohol consumption on the half-life of tetracycline and doxycycline in man","volume":"14","author":"Neuvonen","year":"1976","journal-title":"Int. J. Clini. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0773.1975.tb00768.x","article-title":"Reduced concentrations of plasma diazepam in chronic-alcoholic patients following an oral-administration of diazepam","volume":"36","author":"Sellman","year":"1975","journal-title":"Acta Pharmacol. Tox."},{"issue":"2","key":"10.1016\/j.bcp.2024.116569_b0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2710.2003.00459.x","article-title":"Toxicological interactions involving psychiatric drugs and alcohol: An update","volume":"28","author":"Tanaka","year":"2003","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2024.116569_b0075","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2125.1978.tb00867.x","article-title":"Decline in chlordiazepoxide plasma-levels during fixed-dose therapy of alcohol withdrawal","volume":"6","author":"Sellers","year":"1978","journal-title":"Brit. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116569_b0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cpt1978235535","article-title":"Absorption of oral and intra muscular chlordiazepoxide by alcoholics","volume":"23","author":"Perry","year":"1978","journal-title":"Clin. Pharm. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2024.116569_b0085","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/bja\/56.12.1393","article-title":"Thiopentone pharmacokinetics in patients with chronic alcoholism","volume":"56","author":"Couderc","year":"1984","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.bcp.2024.116569_b0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1592\/phco.25.2.303.56955","article-title":"Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption","volume":"25","author":"Havrda","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00000441-196907000-00005","article-title":"Increased rate of clearance of drugs from circulation of alcoholics","volume":"258","author":"Kater","year":"1969","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0100","first-page":"123","article-title":"Interaction of methadone and ethanol metabolism","volume":"207","author":"Borowsky","year":"1978","journal-title":"J. Pharm. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2024.116569_b0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/00498259209046659","article-title":"Potentiation of heroin and methadone hepatotoxicity by ethanol: an in-vitro study using cultured human hepatocytes","volume":"22","author":"Jover","year":"1992","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.bcp.2024.116569_b0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2044.1984.tb07234.x","article-title":"Preoperative alcohol infusion - the need for analgesic supplementation in chronic-alcoholics","volume":"39","author":"Sthaxholdt","year":"1984","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.bcp.2024.116569_b0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01037943","article-title":"Amitriptyline and ethanol - pharmacokinetic and pharmacodynamic interaction","volume":"25","author":"Dorian","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116569_b0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00542210","article-title":"Biotransformation of amitriptyline in alcoholic depressive patients","volume":"24","author":"Sandoz","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004714-198202000-00002","article-title":"Imipramine disposition in alcoholics","volume":"2","author":"Ciraulo","year":"1982","journal-title":"J. Clin. Psychopharm."},{"issue":"5","key":"10.1016\/j.bcp.2024.116569_b0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/clpt.1988.66","article-title":"Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers","volume":"43","author":"Ciraulo","year":"1988","journal-title":"Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2024.116569_b0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF02220615","article-title":"Carbamazepine kinetics and adverse-effects during and after ethanol exposure in alcoholics and in healthy-volunteers","volume":"43","author":"Sternebring","year":"1992","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116569_b0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/clpt.1981.178","article-title":"Effect of short-term and long-term alcohol-use on phenytoin kinetics in chronic-alcoholics","volume":"30","author":"Sandor","year":"1981","journal-title":"Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2024.116569_b0145","first-page":"657","article-title":"CYP2E1 - Biochemical and toxicological aspects and role in alcohol-induced liver injury","volume":"73","author":"Cederbaum","year":"2006","journal-title":"Mount Sinai J. Med."},{"key":"10.1016\/j.bcp.2024.116569_b0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/biof.5520080116","article-title":"Ethanol-related cytotoxicity catalyzed by CYP2E1-dependent generation of reactive oxygen intermediates in transduced HepG2 cells","volume":"8","author":"Cederbaum","year":"1998","journal-title":"Biofactors"},{"key":"10.1016\/j.bcp.2024.116569_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108677","article-title":"Effects of alcohol-induced increase in CYP2E1 content in human liver microsomes on the activity and cooperativity of CYP3A4","volume":"698","author":"Dangi","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.bcp.2024.116569_b0160","article-title":"Probing functional interactions between cytochromes P450 with principal component analysis of substrate saturation profiles and targeted proteomics","volume":"708","author":"Dangi","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"20","key":"10.1016\/j.bcp.2024.116569_b0165","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1042\/BCJ20170543","article-title":"Toward a systems approach to the human cytochrome P450 ensemble: interactions between CYP2D6 and CYP2E1 and their functional consequences","volume":"474","author":"Davydov","year":"2017","journal-title":"Biochem. J."},{"issue":"23","key":"10.1016\/j.bcp.2024.116569_b0170","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1042\/BCJ20190532","article-title":"Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2","volume":"476","author":"Davydova","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116569_b0175","doi-asserted-by":"crossref","unstructured":"[preprint] K.A. Gaither, D.K. Singh, G. Yue, J. Trudeau, K. Ponraj, N.Y. Davydova, P. Lazarus, D. Davydov, B. Prasad, Effects of alcohol consumption and tobacco smoking on the composition of the ensemble of drug metabolizing enzymes and transporters in human liver, BioRxiv (2024) 2024.05.14.594255.","DOI":"10.1101\/2024.05.14.594255"},{"key":"10.1016\/j.bcp.2024.116569_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109606","article-title":"Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: a systematic review and comprehensive analysis of mechanism of actions","volume":"239","author":"Garel","year":"2022","journal-title":"Drug Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.bcp.2024.116569_b0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40263-022-00897-2","article-title":"Non-parenteral ketamine for depression: a practical discussion on addiction potential and recommendations for judicious prescribing","volume":"36","author":"Swainson","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2024.116569_b0190","article-title":"Antidepressants for the treatment of people with co-occurring depression and alcohol dependence","volume":"4","author":"Agabio","year":"2018","journal-title":"Cochrane Db. Syst. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2024.116569_b0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/hup.935","article-title":"Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study","volume":"23","author":"Altintoprak","year":"2008","journal-title":"Hum. Psychopharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2024.116569_b0200","first-page":"465","article-title":"Integrated cytochrome P450 reaction phenotyping - Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes","volume":"57","author":"Rodrigues","year":"1999","journal-title":"Biochem. Pharm."},{"issue":"6","key":"10.1016\/j.bcp.2024.116569_b0205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2217\/pgs.16.9","article-title":"Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG","volume":"17","author":"Brian","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"12","key":"10.1016\/j.bcp.2024.116569_b0210","first-page":"1493","article-title":"Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches","volume":"28","author":"Venkatakrishnan","year":"2000","journal-title":"Drug. Metab. Disp."},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0215","first-page":"326","article-title":"Application of the relative activity factor approach in scaling from heterologously expressed cytochromes P450 to human liver microsomes: studies on amitriptyline as a model substrate","volume":"297","author":"Venkatakrishnan","year":"2001","journal-title":"J. Pharm. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2024.116569_b0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/dmd.110.035147","article-title":"Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450","volume":"39","author":"Chen","year":"2011","journal-title":"Drug. Metab. Disp."},{"issue":"6","key":"10.1016\/j.bcp.2024.116569_b0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/bdd.760","article-title":"Are there differences in the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9? A systematic investigation into inter-system extrapolation factors","volume":"32","author":"Crewe","year":"2011","journal-title":"Biopharm. Drug. Dispos."},{"issue":"4","key":"10.1016\/j.bcp.2024.116569_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11040168","article-title":"Interpretation of non-clinical data for prediction of human pharmacokinetic parameters: in vitro-In vivo extrapolation and allometric scaling","volume":"11","author":"Choi","year":"2019","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.bcp.2024.116569_b0235","first-page":"319","article-title":"Variables in human liver microsome preparation: impact on the kinetics of L-\u03b1-acetylmethadol (LAAM)-demethylation and dextromethorphan O-demethylation","volume":"29","author":"Nelson","year":"2001","journal-title":"Drug. Metab. Disp."},{"key":"10.1016\/j.bcp.2024.116569_b0240","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.124.001477","article-title":"Differential tissue abundance of membrane-bound drug metabolizing enzymes and transporter proteins by global proteomics","author":"Singh","year":"2024","journal-title":"Drug Metab. Disp."},{"key":"10.1016\/j.bcp.2024.116569_b0245","article-title":"Proteomic analysis of indivifual and pooled preparations of human liver microsomes","author":"Singh","year":"2024","journal-title":"Mendeley Data"},{"issue":"12","key":"10.1016\/j.bcp.2024.116569_b0250","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1080\/00498254.2020.1775913","article-title":"Nonadditivity in human microsomal drug metabolism revealed in a study with coumarin 152, a polyspecific cytochrome P450 substrate","volume":"50","author":"Dangi","year":"2020","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0255","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"issue":"8","key":"10.1016\/j.bcp.2024.116569_b0260","article-title":"High-throughput assay of cytochrome P450-dependent drug demethylation reactions and its use to re-evaluate the pathways of ketamine metabolism","volume":"12","author":"Davydova","year":"2023","journal-title":"Biology-Basel"},{"issue":"8","key":"10.1016\/j.bcp.2024.116569_b0265","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0969-8051(03)00132-X","article-title":"Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple","volume":"30","author":"Krohn","year":"2003","journal-title":"Nucl. Med. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116569_b0270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1145\/366604.366627","article-title":"Algorithm 176: least squares surface fit","volume":"6","author":"Arthurs","year":"1963","journal-title":"Commun. ACM"},{"issue":"2","key":"10.1016\/j.bcp.2024.116569_b0275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0003-9861(95)90017-9","article-title":"High-pressure-induced transitions in microsomal cytochrome P450 2B4 in solution - evidence for conformational inhomogeneity in the oligomers","volume":"320","author":"Davydov","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.bcp.2024.116569_b0280","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/dmd.30.7.853","article-title":"Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes","volume":"30","author":"Hijazi","year":"2002","journal-title":"Drug. Metab. Disp."},{"issue":"51","key":"10.1016\/j.bcp.2024.116569_b0285","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1016\/j.chroma.2010.06.028","article-title":"Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro","volume":"1217","author":"Portmann","year":"2010","journal-title":"J. Chromatogr. A"},{"issue":"4","key":"10.1016\/j.bcp.2024.116569_b0290","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/ALN.0000000000002371","article-title":"Stereoselective ketamine metabolism by genetic variants of cytochrome P450 CYP2B6 and cytochrome P450 oxidoreductase","volume":"129","author":"Wang","year":"2018","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.bcp.2024.116569_b0295","first-page":"887","article-title":"Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes","volume":"29","author":"Yanagihara","year":"2001","journal-title":"Drug. Metab. Disp."},{"issue":"12","key":"10.1016\/j.bcp.2024.116569_b0300","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1248\/cpb.c12-00719","article-title":"Comparison of cytochrome P450 mediated metabolism of three central nervous system acting drugs","volume":"60","author":"Attia","year":"2012","journal-title":"Chem. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.bcp.2024.116569_b0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11419-008-0063-9","article-title":"Roles of polymorphic enzymes CYP2D6 and CYP2C19 for in vitro metabolism of amitriptyline at therapeutic and toxic levels","volume":"27","author":"Jornil","year":"2009","journal-title":"Forensic Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116569_b0310","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000139533","article-title":"Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes","volume":"55","author":"Olesen","year":"1997","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2024.116569_b0315","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/j.1552-4604.1998.tb04399.x","article-title":"Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4","volume":"38","author":"Venkatakrishnan","year":"1998","journal-title":"J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116569_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082562","article-title":"Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy","volume":"8","author":"Preissner","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcp.2024.116569_b0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03602530902843483","article-title":"Polymorphism of human cytochrome P450 enzymes and its clinical impact","volume":"41","author":"Zhou","year":"2009","journal-title":"Drug Metab. Rev."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116569_b0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molbrainres.2004.06.030","article-title":"Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6","volume":"129","author":"Niwa","year":"2004","journal-title":"Mol. Brain Res."},{"issue":"12","key":"10.1016\/j.bcp.2024.116569_b0335","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s12272-013-0212-5","article-title":"Functional influence of human CYP2D6 allelic variations: P34S, E418K, S486T, and R296C","volume":"36","author":"Kim","year":"2013","journal-title":"Arch. Pharm. Res."},{"issue":"11","key":"10.1016\/j.bcp.2024.116569_b0340","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.30.11.1201","article-title":"Effects of G169R and P34S substitutions produced by mutations of CYP2D6*14 on the functional properties of CYP2D6 expressed in V79 cells","volume":"30","author":"Shiraishi","year":"2002","journal-title":"Drug. Metab. Disp."},{"issue":"6","key":"10.1016\/j.bcp.2024.116569_b0345","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.105.003749","article-title":"The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P4502B6 exhibits alterations in substrate metabolism and inactivation","volume":"33","author":"Bumpus","year":"2005","journal-title":"Drug. Metab. Disp."},{"issue":"8","key":"10.1016\/j.bcp.2024.116569_b0350","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1124\/dmd.107.014985","article-title":"Mutation of a single residue (K262R) in p450 2B6 leads to loss of mechanism-based inactivation by phencyclidine","volume":"35","author":"Shebley","year":"2007","journal-title":"Drug. Metab. Disp."},{"issue":"7","key":"10.1016\/j.bcp.2024.116569_b0355","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920009789895534","article-title":"Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6","volume":"10","author":"Mo","year":"2009","journal-title":"Curr. Drug Metab."},{"issue":"9","key":"10.1016\/j.bcp.2024.116569_b0360","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1124\/dmd.112.045302","article-title":"Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs","volume":"40","author":"Walsky","year":"2012","journal-title":"Drug. Metab. Disp."},{"issue":"5","key":"10.1016\/j.bcp.2024.116569_b0365","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1517\/17425255.2011.562194","article-title":"Microsomal monooxygenase as a multienzyme system: the role of P450\u2013P450 interactions","volume":"7","author":"Davydov","year":"2011","journal-title":"Exp. Opin. Drug Metab. Tox."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T22:03:34Z","timestamp":1732831414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224005690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":73,"alternative-id":["S0006295224005690"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116569","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.14.599105","asserted-by":"object"}]},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-additivity of the functional properties of individual P450 species and its manifestation in the effects of alcohol consumption on the metabolism of ketamine and amitriptyline","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116569"}}